← Leaderboards
Raphael Dolin
Harvard University (Medical School)
$47,126,800
Attributed
$65,983,316
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2005–20$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$65,983,316 · 9
By mechanism
UM1$30,691,984 · 1
U01$18,528,628 · 3
U19$16,206,630 · 4
U54$556,074 · 1
Top collaborators
- Daniel R Kuritzkes8 shared
- Kenneth H Mayer7 shared
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- R. Paul Johnson$56,310,063
- Ronald C Desrosiers$52,941,615
- Welkin E Johnson$15,505,977
- Gordon H Williams$31,588,653
- Kenneth C Williams$15,600,819
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchVaccinesClinical TrialsBaseHospitalsWomanClinical Research SiteDolinHiv Vaccine Trials NetworkProgramsCollaborationsHiv InfectionsCommunitiesLeadershipResearch PersonnelPharmacy FacilityResearch Clinical TestingSafetyEvaluationMedical CenterImmunogenicityImmune ResponseImmunityIsrael
Grant awards (45)
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$5,624,553
UM1 · FY2020 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$900,000
UM1 · FY2020 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$6,259,351
UM1 · FY2019 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$3,085,778
UM1 · FY2018 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$3,046,726
UM1 · FY2017 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$3,054,663
UM1 · FY2016 · AI · contact PI
Clinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines$529,032
U19 · FY2016 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$2,781,833
UM1 · FY2015 · AI · contact PI
Clinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines$525,855
U19 · FY2015 · AI · contact PI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)$3,756,870
UM1 · FY2014 · AI · contact PI
Clinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines$589,269
U19 · FY2014 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$1,086,687
UM1 · FY2013 · AI · contact PI
Clinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines$511,546
U19 · FY2013 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$1,095,523
UM1 · FY2012 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine$868,211
U19 · FY2012 · AI · contact PI
Clinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines$366,766
U19 · FY2012 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine$1,241,912
U19 · FY2011 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$933,228
U01 · FY2011 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine$3,105,484
U19 · FY2010 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$923,972
U01 · FY2010 · AI · contact PI
Clinical Core$686,229
U19 · FY2010 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Vectors$1,754,986
U19 · FY2009 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$1,097,943
U01 · FY2009 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine$913,169
U19 · FY2009 · AI · contact PI
Clinical Core$117,212
U19 · FY2009 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Vectors$979,976
U19 · FY2008 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$977,281
U01 · FY2008 · AI · contact PI
Clinical Studies Core$556,074
U54 · FY2008 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine$449,818
U19 · FY2008 · AI · contact PI
Clinical Core$116,264
U19 · FY2008 · AI · contact PI
HIV VACCINE TRIAL CLINICAL UNIT$13,759
U01 · FY2008 · AI · contact PI
Harvard Medical School Vaccine Clinical Trials Unit$1,441,738
U01 · FY2007 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Vectors$1,195,436
U19 · FY2007 · AI · contact PI
Clinical Core$579,979
U19 · FY2007 · AI · contact PI
Clinical Core$684,090
U19 · FY2006 · AI · contact PI
Clinical Evaluation of Novel Adenovirus Vectors$617,636
U19 · FY2006 · AI · contact PI
HIV VACCINE TRIAL CLINICAL UNIT$284,236
U01 · FY2006 · AI · contact PI
HIV VACCINE TRIAL CLINICAL UNIT$1,951,570
U01 · FY2005 · AI
Clinical Core$684,090
U01 · FY2005 · AI
Clinical Evaluation of Novel Adenovirus Vectors$373,760
U19 · FY2005 · AI
HIV VACCINE TRIAL CLINICAL UNIT$2,144,184
U01 · FY2004 · AI
HIV VACCINE TRIAL CLINICAL UNIT$2,081,737
U01 · FY2003 · AI
HIV VACCINE TRIAL CLINICAL UNIT$2,022,330
U01 · FY2002 · AI
HIV VACCINE TRIAL CLINICAL UNIT$1,976,524
U01 · FY2001 · AI
HIV VACCINE TRIAL CLINICAL UNIT$1,996,036
U01 · FY2000 · AI